About Us

Team

Roland Dolle – Director of Chemistry

Dr. Dolle is an Associate Professor in the Department of Biochemistry and Molecular Biophysics. Ron’s expertise includes  medicinal chemistry and many aspects of drug design and preclinical development. His accomplishments include the advancement of more than a dozen drug candidates into preclinical and clinical studies including at least 7 investigational new drug (IND) applications.

Maxene Ilagan – Director of Biology

Dr. Ilagan is an Assistant Professor in the Department of Biochemistry and Molecular Biophysics. Maxene’s expertise includes the development and optimization of high-throughput screening strategies to study cell-based behaviors as well as enzyme or protein function. She also has experience with screening of small molecule and biologics, including sub- or genome-wide siRNA libraries.

 

Management

John Cooper

Dr. Cooper is the Head of the Department of Biochemistry & Molecular Biophysics at Washington University, which is the administrative and physical home for the Center for Drug Discovery. Trained as a physician and pathologist, John’s laboratory research is directed toward understanding the role of the cytoskeleton in regulating cell motility in human diseases such as cancer.

Michael Kinch

Dr. Kinch is an Associate Vice Chancellor and Director of the Center for Research Innovation in Biotechnology. Michael’s expertise include private sector and academic leadership in drug development coupled with detailed analysis of scientific and business trends in the pharmaceutical and the biotechnology industries.

David Perlmutter

Dr. Perlmutter is s Executive Vice chancellor for Medical Affairs and Dean of the School of Medicine at Washington University. David’s expertise includes understanding the role of misfiled proteins and autophagy in inherited genetic diseases such as alpha-1 antitrypsin deficiency. His accomplishments include the E. Mead Johnson Award from the American Pediatric Society, the Sass-Kortsak Award from the Canadian Liver Association and the Shwachman Award from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Holden Thorp

Dr. Thorp is Provost and Executive Vice Chancellor for Academic Affairs at Washington University. Holden’s expertise includes metalloenzyme chemistry and the development of electronic DNA chips. Among his accomplishments, he founded Viamet Pharmaceuticals and Innocrin Pharmaceuticals. His expertise in championing innovation and entrepreneurship also resulted in the publication of his first book, “Engines of Innovation.”